Natera, Inc.

NASDAQ:NTRA

Medical - Diagnostics & Research

Healthcare
$289.50 +0.98%

+$2.23 today

Market cap
$41.98B
Beta
1.54
P/E (TTM)
-143.0
EPS (TTM)
-$1.60
52W Low $131.81High $256.36

Volume 1.96M

Average 1.41M

NTRA Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Natera, Inc.NASDAQ: NTRA

Operating Expenses · Q2 FY2026 · quarter ended Jun 2026

Operating expenses grows, but more slowly than its trailing trend

Q2 FY2026 operating expenses of $560.98M rose 22.6% year over year, behind the +34.5% change in trailing-twelve-month operating expenses. Sequentially, it rose 2.9% from the prior quarter. Over 3 fiscal years it compounded at +25.9% a year.

Context

  • Operating expenses amounted to 78.3% of revenue in FY2025, up 4.9 pp from a year earlier.
  • Operating expenses increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +22.6% toward the trailing-twelve-month pace of +34.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$560.98M+2.9% QoQ
Last fiscal yearDec 2025
$1.81B+45.0% YoY
LTMJun 2026
$2.06B+34.5% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.6%——
1 year+45.0%——
3-year CAGR+25.9%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
1.81B USD
Year-over-year change
+45.0%
4-year CAGR
+23.5%

Operating Expenses vs competitors

How NTRA compares with its peers on the latest reported figures

  • NTRA's LTM Jun 2026 operating expenses of $2.06B is the highest of the 8 companies compared; the peer median is $239.92M.
  • Its year-over-year change of +34.5% is the 4th highest of 8, against a peer median of +24.0%.
  • Operating expenses amounts to 76.0% of revenue for NTRA, versus a peer median of 81.5%.
NTRA Competitors Peer median
Operating Expenses for NTRA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NTRANatera, Inc.LTM Jun 2026$2.06B +34.5%+25.9%76.0%
MYGNMyriad Genetics, Inc.LTM Mar 2026$963.5M +36.4%+1.5%116.2%
WGSGeneDx Holdings Corp.LTM Jun 2026$370.51M +55.7%-21.4%81.5%
VCYTVeracyte, Inc.LTM Jun 2026$309.38M -1.2%+6.6%55.1%
BLLNBillionToOne, Inc.LTM Jun 2026$239.92M +54.2%—60.4%
FLGTFulgent Genetics, Inc.LTM Mar 2026$229.94M +24.0%+5.6%71.8%
PSNLPersonalis, Inc.LTM Mar 2026$111.37M +16.5%-35.7%172.6%
SERASera Prognostics, Inc.LTM Mar 2026$36.51M -0.8%-7.3%64043.9%
Peer median (excluding NTRA) $239.92M+24.0%-2.9%81.5%

Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue625.49M820.22M1.08B1.7B2.31B
Cost of Revenue318.42M456.26M589.83M673.75M810.63M
Gross Profit307.07M363.97M492.74M1.02B1.5B
Gross Margin49.1%44.4%45.5%60.3%64.8%
Research & Development264.21M316.42M320.68M404.14M624.11M
Selling, General & Admin511.03M588.59M618.31M841.31M1.18B
Operating Expenses775.24M905.01M938.99M1.25B1.81B
Depreciation & Amortization11.25M16.7M24.1M30.97M43.48M
EBITDA(451.54M)(520.8M)(397.8M)(148.08M)(220.54M)
EBITDA Margin-72.2%-63.5%-36.7%-8.7%-9.6%
Operating Income(468.17M)(541.04M)(446.25M)(222.29M)(309.91M)
Operating Margin-74.8%-66.0%-41.2%-13.1%-13.4%
Interest Income5.38M3.54M24.35M43.25M45.89M
Interest Expense8.31M9.32M12.64M10.69M4.07M
Other Income / Expenses(2.92M)(5.78M)11.72M32.56M41.82M
Income Before Tax(471.1M)(546.82M)(434.53M)(189.73M)(268.09M)
Pre-Tax Margin-75.3%-66.7%-40.1%-11.2%-11.6%
Income Tax Expense618K978K271K695K(59.93M)
Net Income(471.72M)(547.8M)(434.8M)(190.43M)(208.16M)
Net Margin-75.4%-66.8%-40.2%-11.2%-9.0%
EPS (Basic)(5.21)(5.57)(3.78)(1.53)(1.52)
EPS (Diluted)(5.21)(5.57)(3.78)(1.53)(1.52)
Weighted Avg Shares90.56M98.41M115M124.72M136.72M
Weighted Avg Shares (Diluted)90.56M98.41M115M124.72M136.72M

Natera, Inc.

NASDAQ:NTRA

Intrinsic Alpha fair value

Locked

Current Price

$289.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.